digestive disease which is indicated for surgery
Conditions
Interventions
lansoprazole 15 mg per oral per day for 8 weeks
lansoprazole 30 mg per oral per day for 8 weeks
Sponsors
Department of Surgery, The Jikei University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The patients with digestive disease whichi are indicated for surgery
Exclusion criteria
Exclusion criteria: Patients younger than 20 year old
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the difference of the effectiveness of lansoprazole 15 mg and 30 mg on quality of life after digestive surgery using gastrointestinal symptom rating scale | — |
Countries
Japan
Contacts
Public ContactTakeshi Gocho
Department of Surgery, Gastrointestinal Surgery
Outcome results
None listed